Nuclear Magnetic Resonance Spectrometer Market Share

Global Nuclear Magnetic Resonance (NMR) Spectrometer Market Overview

Nuclear Magnetic Resonance (NMR) Spectrometer Market Size was valued at USD 0.654 Billion in 2022. The Nuclear magnetic resonance (NMR) spectrometer industry is projected to grow from USD 0.689 Billion in 2023 to USD 1.05 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 5.50% during the forecast period (2023 - 2032). Numerous elements, including the growing number of foundations funding biomedical research, the growing need for reasonably priced generic medications, and the expanding application of nuclear magnetic resonance spectroscopy in non-healthcare areas are the key market drivers enhancing the market growth.

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Nuclear Magnetic Resonance (NMR) Spectrometer Market Trends

• 
  

  Applications in biotechnology and pharmaceuticals is driving the market growth

  
  

Nuclear magnetic resonance (NMR) spectrometer demand is primarily being driven by applications in biotechnology and pharmaceuticals. This is because (NMR) spectroscopy is essential for developing these businesses' research, development, and quality assurance.

Another essential use for (NMR) spectrometers is quality control in the pharmaceutical sector. To ensure regulatory compliance and product safety, chemical components must be identified, purified, and consistent. For this purpose, (NMR) spectroscopy is a very reliable method. It enables the accurate assessment of compound structures, confirming that the proper materials are utilized in the production of drugs. The need for (NMR) spectrometers that can adhere to exacting quality control standards keeps growing as authorities increase their examination of pharmaceutical items.

The application of (NMR) spectroscopy in personalized medicine is growing. It supports the development of biomarkers by making it easier to pinpoint certain molecules that can characterize disease states or anticipate patient responses to therapy. Researchers can find biomarkers that enable early disease detection and patient-specific therapy planning by studying biological samples with (NMR). As interest in personalized medicine grows, so does the need for (NMR) spectrometers that can handle challenging biomarker research.

(NMR) spectroscopy is widely used in Fragment-Based Drug Discovery (FBDD), a novel technique to drug development. Researchers can find small molecular fragments that bind to a target molecule by screening libraries of small molecular fragments. By identifying the binding affinity and providing vital structural information on interactions between fragments and targets, (NMR) streamlines this procedure. This speeds up the search for promising medication candidates.

Monoclonal antibodies and vaccines are examples of biopharmaceuticals, which is a section of the pharmaceutical market that is expanding. (NMR) spectroscopy is essential in the careful characterization of these intricate biological components. In order to ensure the efficacy and safety of biopharmaceuticals, it helps to examine the structure, stability, and interactions of those substances. Thus, driving the nuclear magnetic resonance (NMR) spectrometer market revenue.

The first 600MHz NMR spectrometer with a QCI-F cryoprobe to be erected in Australia is currently housed in the Bourne Foundation Nuclear Magnetic Resonance (NMR) Spectroscopy Facility in 2023. This spectrometer significantly boosts the capacity for high throughput sample screening, and the QCI-F Cryoprobe has improved our skills in the developing field of fluorine-19 NMR, a tool that is becoming more and more significant for drug development. Three NMR spectrometers are currently housed in the building, allowing the Institute to investigate new NMR applications in the field of health and medicine.

Nuclear Magnetic Resonance (NMR) Spectrometer Market Segment Insights

Nuclear Magnetic Resonance (NMR) Spectrometer Product Insights

The nuclear magnetic resonance (NMR) spectrometer market segmentation, based on product, includes instruments and consumables. The instruments segment dominated the market in 2022. The need for improved (NMR) spectrometers is driven by rising investments in R&D initiatives across numerous industries, including pharmaceuticals, biotechnology, chemistry, and materials science. Modern tools are needed by researchers to support their investigations and findings.

Nuclear Magnetic Resonance (NMR) Spectrometer Type Insights

The nuclear magnetic resonance (NMR) spectrometer market segmentation, based on type, includes low-field (NMR) spectroscopy and high-field (NMR) spectroscopy. The high-field (NMR) spectroscopy segment dominated the market in 2022. High-field (NMR) spectrometers offer greater sensitivity and resolution compared to lower field apparatus. Because they can evaluate complex samples made up of multiple components, they are very helpful in domains like structural biology, metabolomics, and materials science. (NMR) spectra enable the detection and resolution of minute peaks, giving scientists access to more accurate and comprehensive data.

Figure 1: Nuclear Magnetic Resonance (NMR) Spectrometer Market, by Type, 2022 & 2032 (USD Billion)

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Nuclear Magnetic Resonance (NMR) Spectrometer End-use Insights

The nuclear magnetic resonance (NMR) spectrometer market segmentation, based on end-use, includes academic, pharmaceutical & biotech companies, agriculture & food, chemical industry and others. The pharmaceutical & biotech companies category generated the most income in 2022. Pharmaceutical and biotech companies heavily rely on (NMR) spectroscopy for the creation of novel medications. (NMR) provides essential insights into the structural features of biomolecules, such as proteins and nucleic acids, which are important when examining the interactions between potential medications and their target molecules. This knowledge speeds up the identification and evaluation of potential new drug candidates.

Nuclear Magnetic Resonance (NMR) Spectrometer Regional Insights

By region, the study provides the market insights into North America, Europe, Asia-Pacific and Rest of the World. The North America Nuclear Magnetic Resonance (NMR) Spectrometer Market dominated this market in 2022 (45.80%). Particularly inside the United States, North America is a powerhouse in research and innovation. Leading universities and research centers, including MIT and Stanford, make significant investments in state-of-the-art (NMR) spectrometers to support research in a variety of fields, including chemistry, biology, and materials science. Consistent demand for (NMR) technology is a result of the U.S.'s thriving pharmaceutical and biotechnology industry, which is illustrated by organizations like Pfizer. These businesses use (NMR) spectroscopy for structural analysis, quality control, and drug discovery, leading to advancements in the pharmaceutical sector. Further, the U.S. Nuclear magnetic resonance (NMR) spectrometer market held the largest market share, and the Canada Nuclear magnetic resonance (NMR) spectrometer market was the fastest growing market in the North America region.

Further, the major countries studied in the market report are The U.S., Canada, German, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

Figure 2: NUCLEAR MAGNETIC RESONANCE (NMR) SPECTROMETER MARKET SHARE BY REGION 2022 (USD Billion)

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Europe Nuclear magnetic resonance (NMR) spectrometer market accounts for the second-largest market share. Europe has a long history of outstanding intellectual and scientific achievement. (NMR) spectrometers are used by renowned institutions like the University of Cambridge in the UK to investigate a variety of academic topics, from materials science to molecular biology. (NMR) spectroscopy is used by businesses like Roche in the pharmaceutical and biotechnology sectors of Europe to characterize biopharmaceuticals and create new drugs. Further, the German Nuclear magnetic resonance (NMR) spectrometer market held the largest market share, and the UK Nuclear magnetic resonance (NMR) spectrometer market was the fastest growing market in the European region.

The Asia-Pacific Nuclear Magnetic Resonance (NMR) Spectrometer Market is expected to grow at the fastest CAGR from 2023 to 2032. One of the numerous biopharmaceutical businesses using (NMR) spectroscopy to guarantee the quality and safety of biologic medications is Biocon in India. (NMR) research is driven by collaborative ecosystems, as witnessed in South Korea with organizations like the Korea Basic Science Institute (KBSI). Scientific capacities are strengthened through government assistance, such as that provided by Japan's MEXT (Ministry of Education, Culture, Sports, Science and Technology). Moreover, China’s nuclear magnetic resonance (NMR) spectrometer market held the largest market share, and the Indian Nuclear magnetic resonance (NMR) spectrometer market was the fastest growing market in the Asia-Pacific region.

Nuclear Magnetic Resonance (NMR) Spectrometer Key Market Players & Competitive Insights

Leading market players are investing heavily in research and development in order to expand their product lines, which will help the nuclear magnetic resonance (NMR) spectrometer market, grow even more. Market participants are also undertaking a variety of strategic activities to expand their footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, Nuclear magnetic resonance nmr spectrometer industry must offer cost-effective items.

Manufacturing locally to minimize operational costs is one of the key business tactics used by manufacturers in the nuclear magnetic resonance (NMR) spectrometer industry to benefit clients and increase the market sector. In recent years, the nuclear magnetic resonance (NMR) spectrometer industry has offered some of the most significant advantages to medicine. Major players in the Nuclear magnetic resonance nmr spectrometer market, including JEOL Ltd., Thermo Fisher Scientific Inc., Bruker, Magritek, Oxford Instruments, Nanalysis Corp., Anasazi Instruments, Inc., QOneTec, Advanced Magnetic Resonance Limited and others, are attempting to increase market demand by investing in research and development operations.

JEOL Ltd (JEOL) is a supplier of instruments and equipment for electron optics. The business produces, markets, develops, and conducts research on scientific and metrology instruments, semiconductor equipment, industrial equipment, and medical equipment for high-quality scientific and industrial research and development. In addition, it buys and sells peripherals in addition to processing, maintaining, and offering services for related goods and components. The firm offers these services to many different industries, including those in the fields of aerospace, automotive, agriculture, biotechnology, chemicals, medical, metals and mining, energy, pharmaceuticals, semiconductors, electronics, environment, and forensics. The Americas, Europe, Asia, and Australasia are the regions where Joel sells its products. The headquarters of JEOL are located close to Akishima in Tokyo, Japan.

Thermo Fisher Scientific Inc. (Thermo Fisher) delivers medical equipment, analytical instruments, reagents and consumables, software, and services to satisfy the demands of challenging analytical challenges in research, diagnostics, and clinical laboratories. It offers solutions for cellular biology, synthetic biology, and flow cytometry. Mass spectrometry, genetic sequencing, electron microscopy, protein, and molecular biology research equipment are just a few of the many products that the company sells. The company offers services to companies in the environmental, industrial quality, and process control sectors, as well as to academic and research institutes, governmental organizations, pharmaceutical and biotech companies, clinical diagnostic laboratories, and environmental companies. It provides its products and services through its direct sales force, online sales, and third-party distributors across the Americas, Asia-Pacific, and Europe. The headquarters of Thermo Fisher are located in Waltham, Massachusetts, in the US.

Key Companies in the nuclear magnetic resonance (NMR) spectrometer market include

• 
  

  JEOL Ltd.

  
  


• 
  

  Thermo Fisher Scientific Inc.

  
  


• 
  

  Bruker

  
  


• 
  

  Magritek

  
  


• 
  

  Oxford Instruments

  
  


• 
  

  Nanalysis Corp.

  
  


• 
  

  Anasazi Instruments, Inc.

  
  


• 
  

  QOneTec

  
  


• 
  

  Advanced Magnetic Resonance Limited

  
  

Nuclear Magnetic Resonance (NMR) Spectrometer Industry Developments

April 2023: JEOL Ltd. announced launch of a new Cryogen Reclamation System for Nuclear Magnetic Resonance.

April 2022: With the aid of electron, probe, and optical microscopy, users will be able to highlight the key characteristics of samples using a new software line that Horiba and Digital Surf have developed together.

February 2022: A new product from Bruker has been released that can analyze a sizable protein sample using high-field (NMR). With the new 8mm trosy cryoprobe, precise results are possible.

Nuclear Magnetic Resonance (NMR) Spectrometer Market Segmentation

Nuclear Magnetic Resonance (NMR) Spectrometer Product Outlook

• 
  

  Instruments

  
  


• 
  

  Consumables

  
  

Nuclear Magnetic Resonance (NMR) Spectrometer Type Outlook

• 
  

  Low-field (NMR) Spectroscopy

  
  


• 
  

  High-field (NMR) Spectroscopy

  
  

Nuclear Magnetic Resonance (NMR) Spectrometer End-use Outlook

• 
  

  Academic

  
  


• 
  

  Pharmaceutical & Biotech Companies

  
  


• 
  

  Agriculture & Food

  
  


• 
  

  Chemical Industry

  
  


• 
  

  Others

  
  

Nuclear Magnetic Resonance (NMR) Spectrometer Regional Outlook

• North America
  
  
  
  • US
  
  
  • Canada
  
  
  • Mexico
  
  
  
  


• Europe
  
  
  
  • Germany
  
  
  • UK
  
  
  • France
  
  
  • Italy
  
  
  • Rest of Europe
  
  
  
  


• Asia-Pacific
  
  
  
  • China
  
  
  • India
  
  
  • Japan
  
  
  • South Korea
  
  
  • Australia
  
  
  • Rest of Asia-Pacific
  
  
  
  


• Middle East & Africa
  
  
  
  • Saudi Arabia
  
  
  • Qatar
  
  
  • UAE
  
  
  • Rest of Middle East & Africa
  
  
  
  


• South America
  
  
  
  • Brazil
  
  
  • Argentina
  
  
  • Rest of South America